Published on Web 10/16/2008
New Hyperpolarized Contrast Agents for 13C-MRI from
Para-Hydrogenation of Oligooxyethylenic Alkynes
Francesca Reineri,† Alessandra Viale,† Giovanbattista Giovenzana,‡
Daniela Santelia,† Walter Dastru`,† Roberto Gobetto,† and Silvio Aime*,†
Dipartimento di Chimica IFM, UniVersita` di Torino, Via P. Giuria 7, 10125 Torino, Italy,
DiSCAFF and DFB Center, UniVersita` degli Studi del Piemonte Orientale “A. AVogadro”,
Via BoVio 6, I-28100 NoVara, Italy
Received April 29, 2008; E-mail: silvio.aime@unito.it
Abstract: Two alkyne derivatives, which contain one and two oligooxyethylenic chains respectively, showed
to be good substrates for para-hydrogenation reactions, yielding the corresponding hyperpolarized alkenes
in good yields. A suitable theory has been developed to account for the observed results, fully explaining
the different para-H2 induced effects observed upon the para-hydrogenation of symmetrically and
asymmetrically substituted alkynes in ALTADENA and PASADENA modes. The oligooxyethylenic substituent
provides good water solubility to the para-hydrogenated symmetrical derivative. 13C-MR in vitro images of
the latter derivative were obtained both in acetone and in water solutions (130 mM), using the ALTADENA
procedure and after application of the field cycling procedure which allows acquisition of an in-phase 13C
carbonyl resonance. The finding that the hydrogenated product is water-soluble in contrast to the parent
alkyne which is not allows for the pursuit of a fast phase-transfer separation from the organic solvent, the
unreacted substrate, and the catalyst to obtain a “ready-to-use” water solution suitable for further in vivo
MRI applications.
(PHIP)7,15-21,29-39 methods are currently under intense scrutiny
for the preparation of 13C enriched hyperpolarized substances,
Introduction
for which interesting applications such as 13C-MRI contrast
agents have already been anticipated. With this kind of contrast
agent, images are acquired by the direct detection of the 13C
nucleus, whose endogenous signal is practically zero. The
absence of a background signal allows us to obtain images with
a high signal-to-noise ratio (SNR), where the contrast is given
by the difference in signal intensity between regions reached
by the hyperpolarized 13C molecule and uninvolved zones.8,9
Many efforts have been devoted in recent years to the
development of MR-hyperpolarization procedures, mainly driven
by the potential use of hyperpolarized molecules in Magnetic
Resonance Imaging (MRI) and Magnetic Resonance Spectros-
copy (MRS).1-3In this context, Dynamic Nuclear Polarization
(DNP)9-14,22,23 and Para-Hydrogen Induced Polarization
† Universita` di Torino.
‡ Universita` degli Studi del Piemonte Orientale “A. Avogadro”.
(1) Kauczor, H. U.; Surkau, R.; Roberts, T Eur. Radiol. 1998, 8, 820.
(2) Moller, H. E.; Chen, X. J.; Saam, B.; Hagspiel, K. D.; Johnson, G. A.;
Altes, T. A.; de Lange, E. E.; Kauczor, H. U. Magn. Res. Med. 2002,
47, 1029.
(14) Bhattacharya, P.; Chekmenev, E. Y.; Perman, W. H.; Harris, K. C.;
Lin, A. P.; Norton, V. A.; Tan, C. T.; Ross, B. D.; Weitekamp, D. P.
J. Magn. Reson. 2007, 786, 150.
(15) Ishii, M.; Emami, K.; Kadlecek, S.; Petersson, J. S.; Golman, K.;
Vahdat, V.; Yu, J.; Cadman, R. V.; MacDuffie-Woodburn, J.; Stephen,
M.; Lipson, D. A.; Rizi, R. R. Magn. Res. Med. 2007, 57, 459.
(16) Magnusson, P.; Johansson, E.; Mansson, S.; Petersson, J. S.; Chai,
C. M.; Hansson, G.; Axelsson, O.; Golman, K. Magn. Res. Med. 2007,
57, 1140.
(3) Altes, T. A.; Salerno, M. J. Thoracic Imag. 2004, 19, 250.
(4) Oros, A. M.; Shah, N. J. Phys. Med. Biol. 2004, 49, R105.
(5) Albert, M. S.; Cates, G. D.; Driehuys, B.; Happer, W.; Saam, B.;
Springer, C. S.; Wishnia, A. Nature 1994, 370, 199.
(6) Middleton, H.; Balck, R. D.; Saam, B.; Cates, G. D.; Cofer, G. P.;
Guenther, R.; Happer, W.; Hedlund, L. W.; Johnson, G. A.; Juvan,
K.; Swartz, J. Magn. Reson. Med. 1995, 33, 271.
(17) Goldman, M.; Johannesson, H.; Axelsson, O.; Karlsson, M. Magn.
Res. Imag. 2005, 23, 153.
(7) Golman, K.; Axelsson, O.; Johannesson, H.; Mansson, S.; Olofsson,
C.; Petersson, J. S. Magn. Res. Med. 2001, 46, 1.
(18) Johannesson, H.; Axelsson, O.; Karlsson, M. C. R. Phys. 2004, 5,
315.
(8) Mansson, S.; Johansson, E.; Magnusson, P.; Chai, C. M.; Hansson,
G.; Petersson, J. S.; Stahlberg, F.; Golman, K. Europ. Radiol. 2006,
16, 57, and references therein.
(19) Goldman, M.; Johannesson, H. C. R. Phys. 2005, 6, 575.
(20) Johansson, E.; Olsson, L. E.; Mansson, S.; Petersson, J. S.; Golman,
K.; Stahlberg, F.; Wirestam, R. Magn. Reson. Med. 2004, 52, 1043.
(21) Golman, K.; Olsson, L. E.; Axelsson, O.; Mansson, S.; Karlsson, M.;
Petersson, J. S. Br. J. Radiol 2003, 76, S118.
(9) Golman, K.; Petersson, J. S. Acad. Radiol. 2006, 13, 932, and
references therein.
(10) Golman, K.; Zandt, R.; Thaning, M. Proc. Natl. Acad. Sci. U.S.A.
2006, 103, 11270.
(22) Svensson, J.; Mansson, S.; Johansson, E.; Petersson, J. S.; Olsson,
L. E. Magn. Reson. Med. 2003, 50, 256.
(11) Golman, K.; Zandt, R.; Lerche, M.; Perhson, R.; Ardenkjaer-Larsen,
H. Cancer Res. 2006, 66, 10855.
(23) Kolman, K.; Ardenkjaer-Larsen, J. H.; Petersson, J. S.; Mansson, S.;
Leunbach, I. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 10435.
(24) Abragam, A.; Goldman, M. Rep. Prog. Phys. 1978, 41, 395.
(25) Ardenkjaer-Larsen, J. H.; Fridlund, B.; Gram, A.; Hansson, G.;
Hansson, L.; Lerche, M. H.; Servin, R.; Thaning, M.; Golman, K.
Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 10158.
(12) Golman, K.; Petersson, J. S. Acad. Radiol. 2006, 13, 932.
(13) Kohler, S. J.; Yen, Y.; Wolber, J.; Chen, A. P.; Albers, M. J.; Bok,
R.; Zhang, V.; Trop, J.; Nelson, S.; Vigneron, D. B.; Kurhanewicz,
J.; Hurd, R. E. Magn. Res. Med. 2007, 58, 65.
9
10.1021/ja8059733 CCC: $40.75
2008 American Chemical Society
J. AM. CHEM. SOC. 2008, 130, 15047–15053 15047